Stallergenes Greer is Drug Discovery in United Kingdom that focus on Stallergenes Greer PLC business. Founded in 1962. They cover business area such as Stallergenes Greer PLC, severe allergic rhinitis, allergen immunotherapy, its portfolio, sublingual product, subcutaneous product, veterinary product, Staloral, Oralair, Phostal, Alustal, Alyostal, Albey, enzyme-link immunosorbent, component, prescription service, maximum revenue.
1962
( 62 years old in 2024 )
Stallergenes Greer PLC
-
Tower Bridge House
Saint Katharine's Way
London E1W 1DD
England, United Kingdom
Private
Stallergenes Greer PLCsevere allergic rhinitisallergen immunotherapyits portfoliosublingual productsubcutaneous productveterinary productStaloralOralairPhostalAlustalAlyostal, Albeyenzyme-link immunosorbentcomponentprescription servicemaximum revenue
* We use standard office opening hours in near Stallergenes Greer's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stallergenes Greer is Drug Discovery business from United Kingdom that founded in 1962 (62 years old in 2024), Stallergenes Greer business is focusing on Stallergenes Greer PLC.
Stallergenes Greer headquarter office and corporate office address is located in Tower Bridge House Saint Katharine's Way London E1W 1DD England, United Kingdom.
Stallergenes Greer was founded in United Kingdom.
In 2024, Stallergenes Greer is currently focus on Stallergenes Greer PLC sector.
Above is snippet of Google Trends for "Stallergenes Greer PLC" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stallergenes Greer, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
